Work

Safety and Tolerability of Opicinumab in Relapsing Multiple Sclerosis: the Phase 2b SYNERGY Trial (P5.369)

Year: 2017

Type: article

Source: Neurology

DOI: 10.1212/wnl.88.16_supplement.p5.369

Authors: Peter McCroskery, Krzysztof Selmaj, Oscar Fernandez, Luigi M.E. Grimaldi, Eli Silber, Gabriel Pardo, S. Mitchell Freedman, Yiwei Zhang, Lei Xu, Diego Cadavid, Michelle Mellion

Institutions: Biogen (United States), Medical University of Lodz, Hospital Regional Universitario de Málaga, Instituto de Investigación Biomédica de Málaga, Fondazione Istituto G. Giglio di Cefalù, King's College Hospital, Oklahoma Medical Research Foundation, Raleigh Neurology Associates, Fulcrum Therapeutics (United States)

Language: English

Topic: Multiple Sclerosis Research Studies

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2785570790

FWCI: 2.155

Cites:

Cited by: 11

Related to: 10